Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Theede

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Ugeskrift for Laeger|April 30, 2015
[Cannabinoid hyperemesis syndrome causing prolonged nausea and vomiting in patients with cannabis abuse]Astrid Vinsand Naver, Klaus Theede
Ugeskrift for Laeger|May 22, 2008
[Septic shock after exposure to Vibrio vulnificus]Klaus Theede, Peter Pfeiffer, Hanne Skovbjerg
Danish Medical Journal|December 3, 2014
Increased risk of post-operative complications in patients with Crohn's disease treated with anti-tumour necrosis factor α agents - a systematic reviewAlaa El-Hussuna, Klaus Theede, Gunnar Olaison
Scandinavian Journal of Gastroenterology|October 1, 2016
Randomized clinical trial: a pilot study comparing efficacy of low-dose azathioprine and allopurinol to azathioprine on clinical outcomes in inflammatory bowel diseaseMarianne Kiszka-Kanowitz, Klaus Theede, Anette Mertz-Nielsen
Ugeskrift for Laeger|October 30, 2014
[Optimized thiopurine treatment in chronic inflammatory bowel disease]Marianne Kiszka-Kanowitz, Klaus Theede, Anette Mertz Nielsen
Ugeskrift for Laeger|November 10, 2015
[Optimized thiopurine treatment in chronic inflammatory bowel disease]Marianne Kiszka-Kanowitz, Klaus Theede, Anette Mertz Nielsen
Journal of Crohn'S & Colitis|May 10, 2015
The Impact of Endoscopic Inflammation and Mucosal Healing on Health-related Quality of Life in Ulcerative Colitis PatientsKlaus Theede, Marianne Kiszka-Kanowitz, Inge Nordgaard-Lassen, et al.
Ugeskrift for Laeger|October 9, 2014
[Faecal calprotectin is a useful biomarker for intestinal inflammation]Klaus Theede, Marianne Kiszka-Kanowitz, Inge Nordgaard-Lassen, et al.
Scandinavian Journal of Gastroenterology|February 6, 2014
The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatmentKlaus Theede, Marianne Kiszka-Kanowitz, Anette Mertz Nielsen, et al.
Scandinavian Journal of Gastroenterology|March 5, 2024
Efficacy of optimised thiopurine therapy in patients with moderate-to-severe ulcerative colitis: retrospective long-term follow-up from two randomised trialsAnette Mertz Nielsen, Klaus Theede, Lise Lotte Gluud, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Ugeskrift for Laeger|April 30, 2015
[Cannabinoid hyperemesis syndrome causing prolonged nausea and vomiting in patients with cannabis abuse]Astrid Vinsand Naver, Klaus Theede
Ugeskrift for Laeger|May 22, 2008
[Septic shock after exposure to Vibrio vulnificus]Klaus Theede, Peter Pfeiffer, Hanne Skovbjerg
Danish Medical Journal|December 3, 2014
Increased risk of post-operative complications in patients with Crohn's disease treated with anti-tumour necrosis factor α agents - a systematic reviewAlaa El-Hussuna, Klaus Theede, Gunnar Olaison
Scandinavian Journal of Gastroenterology|October 1, 2016
Randomized clinical trial: a pilot study comparing efficacy of low-dose azathioprine and allopurinol to azathioprine on clinical outcomes in inflammatory bowel diseaseMarianne Kiszka-Kanowitz, Klaus Theede, Anette Mertz-Nielsen
Ugeskrift for Laeger|October 30, 2014
[Optimized thiopurine treatment in chronic inflammatory bowel disease]Marianne Kiszka-Kanowitz, Klaus Theede, Anette Mertz Nielsen
Ugeskrift for Laeger|November 10, 2015
[Optimized thiopurine treatment in chronic inflammatory bowel disease]Marianne Kiszka-Kanowitz, Klaus Theede, Anette Mertz Nielsen
Journal of Crohn'S & Colitis|May 10, 2015
The Impact of Endoscopic Inflammation and Mucosal Healing on Health-related Quality of Life in Ulcerative Colitis PatientsKlaus Theede, Marianne Kiszka-Kanowitz, Inge Nordgaard-Lassen, et al.
Ugeskrift for Laeger|October 9, 2014
[Faecal calprotectin is a useful biomarker for intestinal inflammation]Klaus Theede, Marianne Kiszka-Kanowitz, Inge Nordgaard-Lassen, et al.
Scandinavian Journal of Gastroenterology|February 6, 2014
The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatmentKlaus Theede, Marianne Kiszka-Kanowitz, Anette Mertz Nielsen, et al.
Scandinavian Journal of Gastroenterology|March 5, 2024
Efficacy of optimised thiopurine therapy in patients with moderate-to-severe ulcerative colitis: retrospective long-term follow-up from two randomised trialsAnette Mertz Nielsen, Klaus Theede, Lise Lotte Gluud, et al.
Pageof 3